ICU Medical ROA 2006-2019 | ICUI

Current and historical return on assets (ROA) values for ICU Medical (ICUI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. ICU Medical ROA for the three months ending December 31, 2019 was 9.65%.
ICU Medical ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-12-31 $0.10B $1.69B 6.21%
2019-09-30 $0.07B $1.64B 4.58%
2019-06-30 $0.05B $1.62B 2.95%
2019-03-31 $0.06B $1.61B 3.51%
2018-12-31 $0.03B $1.59B 1.89%
2018-09-30 $0.09B $1.55B 5.68%
2018-06-30 $0.09B $1.53B 5.70%
2018-03-31 $0.02B $1.49B 1.20%
2017-12-31 $0.07B $1.50B 4.62%
2017-09-30 $0.03B $1.52B 2.24%
2017-06-30 $0.05B $1.49B 4.41%
2017-03-31 $0.10B $1.47B 11.56%
2016-12-31 $0.06B $0.71B 9.51%
2016-09-30 $0.06B $0.69B 9.02%
2016-06-30 $0.06B $0.66B 8.83%
2016-03-31 $0.05B $0.64B 8.68%
2015-12-31 $0.05B $0.63B 7.62%
2015-09-30 $0.05B $0.61B 8.26%
2015-06-30 $0.04B $0.57B 6.75%
2015-03-31 $0.03B $0.55B 5.41%
2014-12-31 $0.03B $0.54B 4.96%
2014-09-30 $0.03B $0.53B 6.23%
2014-06-30 $0.04B $0.52B 7.42%
2014-03-31 $0.04B $0.51B 7.89%
2013-12-31 $0.04B $0.50B 8.61%
2013-09-30 $0.04B $0.47B 8.72%
2013-06-30 $0.04B $0.45B 9.24%
2013-03-31 $0.04B $0.44B 10.04%
2012-12-31 $0.04B $0.43B 10.18%
2012-09-30 $0.05B $0.41B 12.18%
2012-06-30 $0.04B $0.39B 11.94%
2012-03-31 $0.04B $0.38B 12.33%
2011-12-31 $0.04B $0.36B 12.75%
2011-09-30 $0.04B $0.34B 10.53%
2011-06-30 $0.04B $0.35B 10.89%
2011-03-31 $0.03B $0.33B 11.09%
2010-12-31 $0.03B $0.31B 10.14%
2010-09-30 $0.03B $0.30B 9.13%
2010-06-30 $0.02B $0.29B 8.05%
2010-03-31 $0.02B $0.29B 7.30%
2009-12-31 $0.03B $0.31B 8.25%
2009-09-30 $0.03B $0.31B 9.44%
2009-06-30 $0.03B $0.30B 10.47%
2009-03-31 $0.03B $0.29B 10.48%
2008-12-31 $0.03B $0.28B 9.43%
2008-09-30 $0.02B $0.27B 8.63%
2008-06-30 $0.02B $0.26B 7.62%
2008-03-31 $0.02B $0.25B 6.84%
2007-12-31 $0.02B $0.24B 9.64%
2007-09-30 $0.03B $0.25B 10.03%
2007-06-30 $0.03B $0.26B 10.55%
2007-03-31 $0.03B $0.25B 12.12%
2006-12-31 $0.03B $0.24B 10.83%
2006-09-30 $0.02B $0.24B 10.41%
2006-06-30 $0.02B $0.23B 10.95%
2006-03-31 $0.02B $0.22B 11.03%
2005-12-31 $0.02B $0.21B 10.58%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.803B $1.266B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.686B 23.40
Medtronic (MDT) Ireland $123.215B 16.57
Stryker (SYK) United States $61.179B 19.77
Boston Scientific (BSX) United States $43.868B 19.76
Baxter (BAX) United States $40.667B 24.82
Lonza Group Ag (LZAGY) Switzerland $30.356B 0.00
Coloplast (CLPBY) Denmark $29.419B 45.40
EssilorLuxottica Societe Anonyme (ESLOY) France $26.277B 0.00
Terumo (TRUMY) Japan $23.940B 29.88
ResMed (RMD) United States $21.189B 36.81
Zimmer Biomet Holdings (ZBH) United States $20.816B 12.81
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $15.108B 0.00
Insulet (PODD) United States $11.175B 683.73
Bio-Rad Laboratories (BIO) United States $10.212B 47.73
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $6.846B 19.69
DiaSorin S.p.A (DSRLF) Italy $6.714B 0.00
Perrigo (PRGO) Ireland $6.335B 11.55
GN STORE NORD (GNNDY) Denmark $5.510B 28.47
Canopy Growth (CGC) Canada $5.296B 0.00
Haemonetics (HAE) United States $5.273B 32.46
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Quidel (QDEL) United States $3.726B 32.71
Neogen (NEOG) United States $3.131B 53.04
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
NuVasive (NUVA) United States $2.614B 20.21
Agios Pharmaceuticals (AGIO) United States $2.586B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.532B 0.00
Envista Holdings (NVST) United States $2.464B 0.00
National Vision Holdings (EYE) United States $1.777B 29.93
Cardiovascular Systems (CSII) United States $1.219B 0.00
AtriCure (ATRC) United States $1.217B 0.00
TG Therapeutics (TGTX) United States $1.175B 0.00
Aurora Cannabis (ACB) Canada $1.058B 0.00
NanoString Technologies (NSTG) United States $0.993B 0.00
Aphria (APHA) $0.887B 0.00
VAREX IMAGING (VREX) United States $0.814B 16.91
Phibro Animal Health (PAHC) United States $0.810B 16.02
InMode (INMD) Israel $0.779B 0.00
Cerus (CERS) United States $0.707B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.628B 113.00
Omeros (OMER) United States $0.611B 0.00
PetIQ (PETQ) United States $0.605B 16.47
Eagle Pharmaceuticals (EGRX) United States $0.581B 34.52
OraSure Technologies (OSUR) United States $0.502B 62.23
Lantheus Holdings (LNTH) United States $0.501B 11.26
LeMaitre Vascular (LMAT) United States $0.489B 27.52
Surmodics (SRDX) United States $0.465B 53.42
Quanterix (QTRX) United States $0.459B 0.00
Zynex (ZYXI) United States $0.364B 39.64
Owens & Minor (OMI) United States $0.350B 9.57
Vapotherm (VAPO) United States $0.343B 0.00
Organigram Holdings (OGI) Canada $0.338B 0.00
Repro-Med Systems (KRMD) United States $0.318B 200.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Meridian Bioscience (VIVO) United States $0.299B 12.02
MacroGenics (MGNX) United States $0.296B 0.00
HEXO (HEXO) $0.295B 0.00
Exagen (XGN) United States $0.219B 0.00
Cytosorbents (CTSO) United States $0.214B 0.00
Female Health (VERU) United States $0.209B 0.00
BioLife Solutions (BLFS) United States $0.206B 126.00
Rockwell Medical (RMTI) United States $0.169B 0.00
Viemed Healthcare (VMD) United States $0.163B 18.39
InfuSystems Holdings (INFU) United States $0.161B 135.33
Evolus (EOLS) United States $0.152B 0.00
United Health Products (UEEC) United States $0.146B 0.00
Bovie Medical (APYX) United States $0.135B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.093B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
Fonar (FONR) United States $0.091B 6.64
Green Organic Dutchman Holdings (TGODF) Canada $0.078B 0.00
MTech Acquisition (KERN) United States $0.077B 0.00
Brainsway (BWAY) Israel $0.073B 0.00
United-Guardian (UG) United States $0.062B 13.08
Nephros (NEPH) United States $0.057B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
GUARDION HEALTH (GHSI) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00